Association of Admission Blood Glucose Level with Major Adverse Cardiac Events in Acute Coronary Syndrome; a Cohort Study
Archives of Academic Emergency Medicine,
Vol. 7 No. 1 (2019),
1 January 2019
,
Page e26
https://doi.org/10.22037/aaem.v7i1.316
Abstract
Introduction: Appropriate management of abnormal admission blood glucose level (ABGL) in acute coronary syndrome (ACS) patients still remains a common issue. This study aims to assess the influence of ABGL on development of 30-day major adverse cardiac events (MACEs) in patients with suspected ACS.
Methods: This is a prospective cohort study based on analysis of data collected from patients suspected to acute coronary syndrome admitted to emergency department. ABGL of patients was measured and its association with development of MACEs (MI, CVA, mortality) within 30 days of follow-up was studied.
Results: 814 participants with the mean age of 61.8 ±13.4 years were studied (58.1% male). MACE endpoints were developed in 166 (39.0%) hyperglycemic, 30 (46.9%) hypoglycemic, and 53 (16.4%) normoglycemic patients (p<0.0001). Mean admission blood glucose level of patients who developed MACE within 30 days was significantly higher than others (210.6±123.4 vs 157.4±86.6mg/dL; p<0.0001; OR: 1.006 (1.005 to 1.008)). There was a significant correlation between male gender (p=0.027), abnormal admission blood glucose level (p<0.001), diabetes (p = 0.001), hypertension (p=0.059), prior CABG (p=0.008), first and second blood troponin levels (p<0.001), first and second abnormal ECGs (p<0.001), and also ECG changes (p<0.001) with developing AMCE. Abnormal ABGL, first and second blood troponin levels, and the history of diabetes were among independent risk factors of developing MACE within 30 days.
Conclusion: It seems that abnormal admission blood glucose level in suspected ACS patients was an independent predictor of major adverse cardiac events within 30 days.
- Blood glucose
- acute coronary syndrome
- myocardial infarction
- stroke
- death
How to Cite
References
Timmer JR, Ottervanger JP, de Boer M-J, Dambrink J-HE, Hoorntje JC, Gosselink AM, et al. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 2005;45(7):999-1002.
Ray KK, Cannon CP, Morrow DA, Kirtane AJ, Buros J, Rifai N, et al. Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. European heart journal. 2007;28(7):806-13.
Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, et al. Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with a first anterior wall acute myocardial infarction. The American journal of cardiology. 2003;92(3):288-91.
Ceriello A, Quagliaro L, D’Amico M, Di Filippo C, Marfella R, Nappo F, et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes. 2002;51(4):1076-82.
Worthley MI, Holmes AS, Willoughby SR, Kucia AM, Heresztyn T, Stewart S, et al. The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes: mediation by superoxide production, resolution with intensive insulin administration. Journal of the American College of Cardiology. 2007;49(3):304-10.
Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, et al. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. American heart journal. 2003;146(4):674-8.
Charpentier S, Cournot M, Lauque D, Girardi C, Bounes V, Elbaz M, et al. Usefulness of initial glucose level to improve acute coronary syndrome diagnosis in the emergency department. Emergency Medicine Journal. 2011;28(7):564-8.
Petursson P, Herlitz J, Caidahl K, Gudbjornsdottir S, Karlsson T, Perers E, et al. Admission glycaemia and outcome after acute coronary syndrome. International journal of cardiology. 2007;116(3):315-20.
Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. 2005;111(23):3078-86.
Weston C, Walker L, Birkhead JJH. Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome. 2007;93(12):1542-6.
Dandona P, Chaudhuri A, Ghanim H, Mohanty PJRicm. Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes. 2006;7:S25-34.
NICE CfCPa. Hyperglycaemia in Acute Coronary Syndromes: Management of Hyperglycaemia in People with Acute Coronary Syndromes. 2011.
Ishihara MJCJ. Acute hyperglycemia in patients with acute myocardial infarction. 2012;76(3):563-71.
Gardner LS, Nguyen-Pham S, Greenslade JH, Parsonage W, D'emden M, Than M, et al. Admission glycaemia and its association with acute coronary syndrome in Emergency Department patients with chest pain. 2015;32(8):608-12.
Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K, et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. 2003;89(5):512-6.
Dong-bao L, Qi H, Jincheng G, Hong-wei L, Hui C, Shu-mei ZJIM. Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with ST-elevation acute myocardial infarction. 2011;50(21):2471-5.
Capes SE, Hunt D, Malmberg K, Gerstein HCJTL. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. 2000;355(9206):773-8.
Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. 2008;117(12):1610-9.
Oswald G, Smith C, Betteridge D, Yudkin JJBMJ. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. 1986;293(6552):917-22.
Norhammar A, Tenerz Ã…, Nilsson G, Hamsten A, EfendÃc S, Rydén L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. 2002;359(9324):2140-4.
- Abstract Viewed: 436 times
- PDF Downloaded: 270 times
- HTML Downloaded: 72 times
